Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors

By sjmartinez • August 19, 2024

Mederos MA, Court CM, Dipardo BJ, Pisegna JR, Dawson DW, Joe Hines O, Donahue TR, Graeber TG, Girgis MD, Tomlinson JS. Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors. J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27830. Epub ahead of print. PMID: 39155697.

Tags: Digestive Diseases, genomic biomarker, pancreatic neuroendocrine tumor, prognosis, Publications, recurrence, Veterans Administration, whole‐exome sequencing

Successful novel use of dupilumab for gastrointestinal involvement of idiopathic hypereosinophilic syndrome: case report and review of the literature

Moffatt C, Soriano C, Dawson DW, Weiss GA. Successful novel use of dupilumab for gastrointestinal involvement of idiopathic hypereosinophilic syndrome: case report and review of[...]

The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease

Rosas US, Almario CV, Yu KS, Spiegel BMR. The Cost Effectiveness of Adjunctive Treatments for Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. Clin Drug Investig. 2024[...]

Summary: Guidewires in GI endoscopy

American Society for Gastrointestinal Endoscopy Technology Committee; Han S, Girotra M, Akshintala VS, Chen D, Chen YI, Das KK, Kahn A, Mishra G, Muthusamy VR,[...]